BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15758327)

  • 1. Novel paradigm on the effect of estrogen on bone.
    Järvinen TL
    J Musculoskelet Neuronal Interact; 2003 Dec; 3(4):374-80; discussion 381. PubMed ID: 15758327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and bone--a reproductive and locomotive perspective.
    Järvinen TL; Kannus P; Sievänen H
    J Bone Miner Res; 2003 Nov; 18(11):1921-31. PubMed ID: 14606503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.
    Riggs BL; Khosla S; Melton LJ
    J Bone Miner Res; 1998 May; 13(5):763-73. PubMed ID: 9610739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal osteoporosis and hormone replacement therapy.
    Gambacciani M; Vacca F
    Minerva Med; 2004 Dec; 95(6):507-20. PubMed ID: 15785435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of pattern of menopausal transition on the amount of trabecular bone loss. Results from a 6-year prospective longitudinal study.
    Seifert-Klauss V; Link T; Heumann C; Luppa P; Haseitl M; Laakmann J; Rattenhuber J; Kiechle M
    Maturitas; 2006 Nov; 55(4):317-24. PubMed ID: 16781095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss].
    Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoporosis in experimental postmenopausal polyarthritis: the relative contributions of estrogen deficiency and inflammation.
    Jochems C; Islander U; Erlandsson M; Verdrengh M; Ohlsson C; Carlsten H
    Arthritis Res Ther; 2005; 7(4):R837-43. PubMed ID: 15987485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An expanded overview of postmenopausal osteoporosis.
    Marcus R
    J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):195-7. PubMed ID: 15758431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective estrogen receptor modulators: A possible new treatment of osteoporosis in males.
    Kastelan D; Giljevic Z; Kraljevic I; Korsic M
    Med Hypotheses; 2006; 67(5):1052-3. PubMed ID: 16790322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen deficiency, T cells and bone loss.
    Pacifici R
    Cell Immunol; 2008; 252(1-2):68-80. PubMed ID: 17888417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.
    North American Menopause Society
    Menopause; 2006; 13(3):340-67; quiz 368-9. PubMed ID: 16735931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between BMD, dental panoramic radiographic findings and biochemical markers of bone turnover in diagnosis of osteoporosis.
    Vlasiadis KZ; Damilakis J; Velegrakis GA; Skouteris CA; Fragouli I; Goumenou A; Matalliotakis J; Koumantakis EE
    Maturitas; 2008 Mar; 59(3):226-33. PubMed ID: 18342460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-dependent increase in bone turnover and bone loss in postmenopausal women with breast cancer treated with anastrozole. Prevention with bisphosphonates.
    Confavreux CB; Fontana A; Guastalla JP; Munoz F; Brun J; Delmas PD
    Bone; 2007 Sep; 41(3):346-52. PubMed ID: 17618847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZT-031, a cyclized analog of parathyroid hormone(1-31) for the potential treatment of osteoporosis.
    Nemeth EF
    IDrugs; 2008 Nov; 11(11):827-40. PubMed ID: 18988128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview: animal models of osteopenia and osteoporosis.
    Jee WS; Yao W
    J Musculoskelet Neuronal Interact; 2001 Mar; 1(3):193-207. PubMed ID: 15758493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis-an update.
    Lamichhane AP
    JNMA J Nepal Med Assoc; 2005; 44(158):60-6. PubMed ID: 16568580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroids and the construction and conservation of the adult skeleton.
    Riggs BL; Khosla S; Melton LJ
    Endocr Rev; 2002 Jun; 23(3):279-302. PubMed ID: 12050121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the risk factors for osteoporosis among postmenopausal women.
    Demir B; Haberal A; Geyik P; Baskan B; Ozturkoglu E; Karacay O; Deveci S
    Maturitas; 2008; 60(3-4):253-6. PubMed ID: 18778903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related changes in marmoset trabecular and cortical bone and response to alendronate therapy resemble human bone physiology and architecture.
    Bagi CM; Volberg M; Moalli M; Shen V; Olson E; Hanson N; Berryman E; Andresen CJ
    Anat Rec (Hoboken); 2007 Aug; 290(8):1005-16. PubMed ID: 17610276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.